Verizon executive Kyle Malady sells 1,100 shares

Available on EDGAR 11/12/2026 - 01:30 PM EST Accepted by SEC EDGAR 11/12/2026 - 01:30 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Verizon Communications Inc. (VZ) EVP and Group CEO-VZ Business Kyle Malady sold 1,100 shares of common stock at $46.11 per share on November 10, 2026. The sale was executed under a Rule 10b5-1 trading plan adopted May 18, 2026. After the sale, Malady held 96,666 shares directly and 20,527 shares indirectly through a 401(k).

Insider Trade Summary 10b5-1

Net Seller: 1,100 shares

Net Sell 1 txn

Insider Malady Kyle

Role EVP and Group CEO-VZ Business

Sold 1,100 shs ($51K)

Share of Position Sold 1.1%

Type	Security	Shares	Price	Value
Sale	Common Stock F1	1,100	$46.11	$51K
Holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 96,666 shares (Direct); Common Stock — 20,527 shares (Indirect, By 401(k))

Holdings Before and After: Common Stock, 97,766 to 96,666 shares (Direct)

Footnotes (1)

1. F1. This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 18, 2026.

Key Figures

Common shares sold: 1,100 shares Sale price: $46.11 per share Direct shares following transaction: 96,666 shares +1 more

4 metrics

Common shares sold 1,100 shares Kyle Malady's sale on November 10, 2026

Sale price $46.11 per share Kyle Malady's sale on November 10, 2026

Direct shares following transaction 96,666 shares Reported after the November 10, 2026 sale

Indirect shares held through 401(k) 20,527 shares Reported on November 10, 2026

Key Terms

Rule 10b5-1 trading plan

1 terms

Rule 10b5-1 trading plan regulatory

"executed pursuant to a Rule 10b5-1 trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many shares did VZ executive Kyle Malady sell, and at what price?

Kyle Malady, EVP and Group CEO-VZ Business at Verizon Communications Inc., sold 1,100 shares of common stock at $46.11 per share on November 10, 2026. The sale was under a Rule 10b5-1 trading plan adopted May 18, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Malady Kyle

(Last) (First) (Middle)

VERIZON COMMUNICATIONS INC.

1095 AVENUE OF THE AMERICAS

(Street)

NEW YORK NEW YORK 10036

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
VERIZON COMMUNICATIONS INC [ VZ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP and Group CEO-VZ Business

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
11/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/10/2026		S(1)		1,100	D	$46.11	96,666	D
Common Stock								20,527	I	By 401(k)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 18, 2026.

Remarks:

	Evgeniya Berezkina, Attorney-in-fact for Kyle Malady	11/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)